Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jushi HoldingsJUSH 51 9-Day RSI is 47.66 as of Aug. 01, 2026. GuruFocus rates JUSH with a GF Score™ of 51/100 and a GF Value™ of $0.53 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,047 Drug Manufacturers companies, Jushi Holdings ranks better than 50.05% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-01), Jushi Holdings's 9-Day RSI is 47.66.
The industry rank for Jushi Holdings's 9-Day RSI or its related term are showing as below:
JUSH's 9-Day RSI is ranked better than 50.05% of 1047
companies
in the Drug Manufacturers industry
Industry Median: 46.02
vs JUSH: 47.66
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Jushi Holdings 9-Day RSI Related Terms
JUSH vs ZTS: 9-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jushi Holdings 9-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Jushi Holdings's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jushi Holdings (JUSH) has a 9-Day RSI of 47.66 as of Aug. 01, 2026. According to the industry distribution chart, Jushi Holdings ranks #523 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 50%.
Is Jushi Holdings' 9-Day RSI too high?
Jushi Holdings' current 9-Day RSI is 47.66. The Drug Manufacturers industry median 9-Day RSI is 46.02. Jushi Holdings' value of 47.66 is 3.6% above this industry median. Based on the distribution chart, Jushi Holdings ranks #523 out of 1047 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jushi Holdings has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jushi Holdings' 9-Day RSI compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jushi Holdings ranks #523 out of 1047 companies for 9-Day RSI. This puts Jushi Holdings in the upper half of its industry. The industry median 9-Day RSI is 46.02. Jushi Holdings' value of 47.66 is 3.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 46.02, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jushi Holdings's current 9-Day RSI of 47.66 is 3.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 46.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jushi Holdings's current 9-Day RSI is 47.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jushi Holdings stock overvalued right now?
Based on GuruFocus' analysis, Jushi Holdings (JUSH) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.53, compared to a current price of $0.42 — trading 20.7% below its estimated fair value. The current 9-Day RSI is 47.66 and 3.6% above the Drug Manufacturers industry median of 46.02. Jushi Holdings' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Jushi Holdings (JUSH), the current 9-Day RSI is 47.66 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jushi Holdings (JUSH) Overvalued in 2026?
Based on GuruFocus' analysis, Jushi Holdings stock appears to be undervalued.
The current stock price of $0.42 is trading 20.7% below its estimated GF Value™ of $0.53.
GuruFocus considers Jushi Holdings to be Modestly Undervalued.
Key valuation signals for JUSH:
9-Day RSI: 47.66
GF Value™: $0.53 vs. price of $0.42 (20.7% below fair value)
Industry Position: 3.6% above the Drug Manufacturers median (#523 of 1047)
No single metric tells the full story. See the JUSH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature's Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
51GF Score
Get the complete analysis for JUSH
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUSH has been successfully added to your 
